Tech Company Financing Transactions
Virxsys Funding Round
Signature Capital participated in a $9.8 million venture round for Virxsys. The round was announced on 12/31/2009.
Transaction Overview
Company Name
Announced On
12/31/2009
Transaction Type
Venture Equity
Amount
$9,808,000
Round
Undisclosed
Investors
Signature Capital (William Sick)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
200 Perry Parkway 1A
Gaithersburg, MD 20877
USA
Gaithersburg, MD 20877
USA
Phone
Website
Email Address
Overview
Founded in 1998, VIRxSYS Corporation is a privately-held biotechnology company which focuses on gene therapy. The field of gene therapy holds great promise. However, most of these promises have been unfulfilled due to challenges in developing a transport system that delivers genetic and therapeutic payloads into targeted cells efficiently, reproducibly, and permanently.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lawrence Michaelis
VP - R & D
Laurent Humeau
VP - Regulatory Affairs
Randy Hedin
Browse more venture capital transactions:
Prev: 12/31/2009: Neurotech Pharmaceuticals venture capital transaction
Next: 12/31/2009: LiveIntent venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs